319 related articles for article (PubMed ID: 28983804)
1. Arrhythmogenic Cardiomyopathy: the Guilty Party in Adipogenesis.
Stadiotti I; Catto V; Casella M; Tondo C; Pompilio G; Sommariva E
J Cardiovasc Transl Res; 2017 Dec; 10(5-6):446-454. PubMed ID: 28983804
[TBL] [Abstract][Full Text] [Related]
2. Cardiac mesenchymal stromal cells are a source of adipocytes in arrhythmogenic cardiomyopathy.
Sommariva E; Brambilla S; Carbucicchio C; Gambini E; Meraviglia V; Dello Russo A; Farina FM; Casella M; Catto V; Pontone G; Chiesa M; Stadiotti I; Cogliati E; Paolin A; Ouali Alami N; Preziuso C; d'Amati G; Colombo GI; Rossini A; Capogrossi MC; Tondo C; Pompilio G
Eur Heart J; 2016 Jun; 37(23):1835-46. PubMed ID: 26590176
[TBL] [Abstract][Full Text] [Related]
3. Cyclophilin A in Arrhythmogenic Cardiomyopathy Cardiac Remodeling.
Rurali E; Pilato CA; Perrucci GL; Scopece A; Stadiotti I; Moschetta D; Casella M; Cogliati E; Sommariva E; Pompilio G; Nigro P
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31096574
[TBL] [Abstract][Full Text] [Related]
4. Deciphering the Role of Wnt and Rho Signaling Pathway in iPSC-Derived ARVC Cardiomyocytes by In Silico Mathematical Modeling.
Parrotta EI; Procopio A; Scalise S; Esposito C; Nicoletta G; Santamaria G; De Angelis MT; Dorn T; Moretti A; Laugwitz KL; Montefusco F; Cosentino C; Cuda G
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670616
[TBL] [Abstract][Full Text] [Related]
5. Intracellular calcium current disorder and disease phenotype in
Chen P; Xiao Y; Wang Y; Zheng Z; Chen L; Yang X; Li J; Wu W; Zhang S
Theranostics; 2020; 10(24):11215-11229. PubMed ID: 33042279
[TBL] [Abstract][Full Text] [Related]
6. Restrictive loss of plakoglobin in cardiomyocytes leads to arrhythmogenic cardiomyopathy.
Li D; Liu Y; Maruyama M; Zhu W; Chen H; Zhang W; Reuter S; Lin SF; Haneline LS; Field LJ; Chen PS; Shou W
Hum Mol Genet; 2011 Dec; 20(23):4582-96. PubMed ID: 21880664
[TBL] [Abstract][Full Text] [Related]
7. Distinct molecular signature of phospholamban p.Arg14del arrhythmogenic cardiomyopathy.
Te Rijdt WP; Asimaki A; Jongbloed JDH; Hoorntje ET; Lazzarini E; van der Zwaag PA; de Boer RA; van Tintelen JP; Saffitz JE; van den Berg MP; Suurmeijer AJH
Cardiovasc Pathol; 2019; 40():2-6. PubMed ID: 30763825
[TBL] [Abstract][Full Text] [Related]
8. A case of arrhythmogenic right ventricular cardiomyopathy (ARVC/D) in which tenascin C immunostaining made the assessment of myocardial remodeling possible.
Kondo T
Soud Lek; 2014 Jul; 59(3):24-5. PubMed ID: 25186773
[TBL] [Abstract][Full Text] [Related]
9. Profiling of differentially expressed microRNAs in arrhythmogenic right ventricular cardiomyopathy.
Zhang H; Liu S; Dong T; Yang J; Xie Y; Wu Y; Kang K; Hu S; Gou D; Wei Y
Sci Rep; 2016 Jun; 6():28101. PubMed ID: 27307080
[TBL] [Abstract][Full Text] [Related]
10. Electrical dysfunctions in human-induced pluripotent stem cell-derived cardiomyocytes from a patient with an arrhythmogenic right ventricular cardiomyopathy.
El-Battrawy I; Zhao Z; Lan H; Cyganek L; Tombers C; Li X; Buljubasic F; Lang S; Tiburcy M; Zimmermann WH; Utikal J; Wieland T; Borggrefe M; Zhou XB; Akin I
Europace; 2018 Jun; 20(FI1):f46-f56. PubMed ID: 29566126
[TBL] [Abstract][Full Text] [Related]
11. Myocardial expression profiles of candidate molecules in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia compared to those with dilated cardiomyopathy and healthy controls.
Akdis D; Medeiros-Domingo A; Gaertner-Rommel A; Kast JI; Enseleit F; Bode P; Klingel K; Kandolf R; Renois F; Andreoletti L; Akdis CA; Milting H; Lüscher TF; Brunckhorst C; Saguner AM; Duru F
Heart Rhythm; 2016 Mar; 13(3):731-41. PubMed ID: 26569459
[TBL] [Abstract][Full Text] [Related]
12. Arrhythmogenic right ventricular cardiomyopathy: clinicopathologic correlation based on a revised definition of pathologic patterns.
d'Amati G; Leone O; di Gioia CR; Magelli C; Arpesella G; Grillo P; Marino B; Fiore F; Gallo P
Hum Pathol; 2001 Oct; 32(10):1078-86. PubMed ID: 11679942
[TBL] [Abstract][Full Text] [Related]
13. Generation of patient-specific induced pluripotent stem cell-derived cardiomyocytes as a cellular model of arrhythmogenic right ventricular cardiomyopathy.
Ma D; Wei H; Lu J; Ho S; Zhang G; Sun X; Oh Y; Tan SH; Ng ML; Shim W; Wong P; Liew R
Eur Heart J; 2013 Apr; 34(15):1122-33. PubMed ID: 22798562
[TBL] [Abstract][Full Text] [Related]
14. Modeling of arrhythmogenic right ventricular cardiomyopathy with human induced pluripotent stem cells.
Caspi O; Huber I; Gepstein A; Arbel G; Maizels L; Boulos M; Gepstein L
Circ Cardiovasc Genet; 2013 Dec; 6(6):557-68. PubMed ID: 24200905
[TBL] [Abstract][Full Text] [Related]
15. Genetic fate mapping identifies second heart field progenitor cells as a source of adipocytes in arrhythmogenic right ventricular cardiomyopathy.
Lombardi R; Dong J; Rodriguez G; Bell A; Leung TK; Schwartz RJ; Willerson JT; Brugada R; Marian AJ
Circ Res; 2009 May; 104(9):1076-84. PubMed ID: 19359597
[TBL] [Abstract][Full Text] [Related]
16. [Arrhythmogenic right ventricular cardiomyopathy].
Wang QW; Liu L
Fa Yi Xue Za Zhi; 2004; 20(1):35-6, 39. PubMed ID: 15150878
[TBL] [Abstract][Full Text] [Related]
17. Adipositas cordis, fatty infiltration of the right ventricle, and arrhythmogenic right ventricular cardiomyopathy. Just a matter of fat?
Basso C; Thiene G
Cardiovasc Pathol; 2005; 14(1):37-41. PubMed ID: 15710290
[TBL] [Abstract][Full Text] [Related]
18. Severe Cardiac Dysfunction and Death Caused by Arrhythmogenic Right Ventricular Cardiomyopathy Type 5 Are Improved by Inhibition of Glycogen Synthase Kinase-3β.
Padrón-Barthe L; Villalba-Orero M; Gómez-Salinero JM; Domínguez F; Román M; Larrasa-Alonso J; Ortiz-Sánchez P; Martínez F; López-Olañeta M; Bonzón-Kulichenko E; Vázquez J; Martí-Gómez C; Santiago DJ; Prados B; Giovinazzo G; Gómez-Gaviro MV; Priori S; Garcia-Pavia P; Lara-Pezzi E
Circulation; 2019 Oct; 140(14):1188-1204. PubMed ID: 31567019
[TBL] [Abstract][Full Text] [Related]
19. Arrhythmogenic cardiomyopathy: pathology, genetics, and concepts in pathogenesis.
Hoorntje ET; Te Rijdt WP; James CA; Pilichou K; Basso C; Judge DP; Bezzina CR; van Tintelen JP
Cardiovasc Res; 2017 Oct; 113(12):1521-1531. PubMed ID: 28957532
[TBL] [Abstract][Full Text] [Related]
20. Excess TGF-β1 Drives Cardiac Mesenchymal Stromal Cells to a Pro-Fibrotic Commitment in Arrhythmogenic Cardiomyopathy.
Maione AS; Stadiotti I; Pilato CA; Perrucci GL; Saverio V; Catto V; Vettor G; Casella M; Guarino A; Polvani G; Pompilio G; Sommariva E
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
